Hanns-christian Tillmann
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Safety of Remibrutinib in Chronic Spontaneous Urticaria: A Pooled Analysis of REMIX-1 and REMIX-2 Trials.
Journal: The journal of allergy and clinical immunology. In practice
Published: March 02, 2026
Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma.
Journal: Journal of asthma and allergy
Published: October 11, 2022
Corrigendum to "Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/indacaterol/glycopyrronium in patients with asthma" [Pulm. Pharmacol. Therapeut. 70 (2021) 102068].
Journal: Pulmonary pharmacology & therapeutics
Published: April 15, 2022
A Review of the Unique Drug Development Strategy of Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A First-in-Class, Once-Daily, Single-Inhaler, Fixed-Dose Combination Treatment for Asthma.
Journal: Advances in therapy
Published: October 29, 2021
Effect of indacaterol/glycopyrronium on ventilation and perfusion in COPD: a randomized trial.
Journal: Respiratory research
Published: August 12, 2021
Population Pharmacokinetic Analysis of Indacaterol/Glycopyrronium/Mometasone Furoate After Administration of Combination Therapies Using the Breezhaler® Device in Patients with Asthma.
Journal: European journal of drug metabolism and pharmacokinetics
Published: April 23, 2021
Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma.
Journal: Clinical drug investigation
Published: March 22, 2021
Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/ indacaterol/glycopyrronium in patients with asthma.
Journal: Pulmonary pharmacology & therapeutics
Published: January 06, 2021
Lung function improvements following inhaled indacaterol/glycopyrronium/mometasone furoate are independent of dosing time in asthma patients: a randomised trial.
Journal: ERJ open research
Published: June 24, 2020
Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate following once-daily inhalation as a combination in healthy subjects.
Journal: Pulmonary pharmacology & therapeutics
Published: March 28, 2020
Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate administered as an inhaled fixed-dose combination in Japanese and Caucasian healthy subjects.
Journal: BMC pulmonary medicine
Published: February 19, 2020
Last Updated: 09/26/2026